Tuesday, November 27   Wednesday, November 28   Thursday, November 29        
 
All times are Local Paris
Concorde

Napoleon
   
8:00 AM
GlaxoSmithKline
Duncan Learmouth, VP IR
Genset*
Andre Pernet, President & CEO
8:35 AM
Elan Corporation, plc
Thomas Lynch, Executive Vice Chairman
NicOx S.A.
Michele Garufi, Chairman & CEO
9:10 AM
Gambro AB
Lars Granlof, SVP & CFO
First Health Group Corp.
James C. Smith, Chairman & CEO
9:45 AM
Tenet Healthcare Corp.*
Thomas B. Mackey, COO
CV Therapeutics, Inc.
Louis G. Lange, Chairman & CEO
10:20 AM
Biogen, Inc.*
Robert Hamm, VP International
Introgen Therapeutics, Inc.
James A. Merritt, VP, Clinical Affairs
10:55 AM
SkyePharma plc
Michael Ashton, CEO
Health Net, Inc.
David Olson, Sr. VP, IR
11:30 AM
  • Professor Stuart Montgomery
  • Dr. Virinder Nohria Asst. Prof.,
    Emory University School of Medicine, Atlanta
  • Professor Rob W. Kerwin
    Institute of Psychiatry, King's College, London
    		•
    Bruker AXS
    Martin Haas, CEO
    12:30 PM
    14:00 PM
    Novo Nordisk
    Mads Krogsgaard Thomsen, CSO
    Allos Therapeutics, Inc.
    Michael E. Hart, CFO & SVP
    14:35 PM
    ICOS Corporation
    Thomas P. St. John, VP, Therapeutic Development
    Kendle International Inc.
    Tim Mooney, EVP & CFO
    15:10 PM
    Pyrosequencing AB
    Erik Wallden, President & CEO
    15:45 PM
    Protein Design Labs, Inc.
    Laurence Jay Korn, CEO & Chairperson
    IMS Health
    Gilles Pajot, EVP
    16:20 PM
    King Pharmaceuticals, Inc.
    Kyle Macione, EVP Corporate Affairs
    Exelixis, Inc.
    George Scangos, President & CEO
    16:55 PM
    Enzon, Inc.
    Arthur J. Higgins, President & CEO
    ImmunoGen, Inc.
    Mitchel Sayare, Chairman & CEO
    17:30 PM
    Serono S.A.*
    Stuart Grant, VP Corporate Finance
    Modex
    Dr. Jacques Essinger, CEO
    * No Webcast Available 


    		If you do not have Real Player
    Click here to Download    		 Windows Media If you do not have Windows Media Player
    Click here to download